02 Feb, 2018
A press release has also been published with more information about the exciting and innovative PREPARE’s ALIC4E clinical trial. This is the only study that is currently randomizing patients to receive antiviral treatment or not. This study will answer the question about whether Oseltamivir is clinically and/or cost effective or not when treating primary care patients with influenza-like illness.
PENTA is partner in PREPARE (Platform for European Preparedness Against (Re-)emerging Epidemics) project, an EU funded network for harmonised large-scale clinical research studies on infectious diseases, prepared to rapidly respond to any severe ID outbreak, providing real-time evidence for clinical management of patients and for informing public health responses.
To know more about the project, visit the PREPARE website.